- Home
- EBON vs BIVI Comparison
EBON vs BIVI Comparison
Compare EBON & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EBON
- BIVI
- Stock Information
- Founded
- EBON 2010
- BIVI 2013
- Country
- EBON China
- BIVI United States
- Employees
- EBON N/A
- BIVI N/A
- Industry
- EBON Semiconductors
- BIVI Biotechnology: Pharmaceutical Preparations
- Sector
- EBON Technology
- BIVI Health Care
- Exchange
- EBON Nasdaq
- BIVI Nasdaq
- Market Cap
- EBON 21.2M
- BIVI 15.1M
- IPO Year
- EBON 2020
- BIVI N/A
- Fundamental
- Price
- EBON $3.95
- BIVI $1.12
- Analyst Decision
- EBON
- BIVI Strong Buy
- Analyst Count
- EBON 0
- BIVI 1
- Target Price
- EBON N/A
- BIVI $30.00
- AVG Volume (30 Days)
- EBON 6.2K
- BIVI 757.2K
- Earning Date
- EBON 04-28-2025
- BIVI 05-13-2025
- Dividend Yield
- EBON N/A
- BIVI N/A
- EPS Growth
- EBON N/A
- BIVI N/A
- EPS
- EBON N/A
- BIVI N/A
- Revenue
- EBON $5,868,771.00
- BIVI N/A
- Revenue This Year
- EBON N/A
- BIVI N/A
- Revenue Next Year
- EBON N/A
- BIVI N/A
- P/E Ratio
- EBON N/A
- BIVI N/A
- Revenue Growth
- EBON 20.88
- BIVI N/A
- 52 Week Low
- EBON $3.00
- BIVI $0.62
- 52 Week High
- EBON $10.94
- BIVI $7.50
- Technical
- Relative Strength Index (RSI)
- EBON 59.51
- BIVI 59.89
- Support Level
- EBON $3.42
- BIVI $1.04
- Resistance Level
- EBON $3.64
- BIVI $1.29
- Average True Range (ATR)
- EBON 0.19
- BIVI 0.13
- MACD
- EBON 0.08
- BIVI 0.05
- Stochastic Oscillator
- EBON 96.49
- BIVI 74.50
About EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services. Its geographic regions are Mainland China, Australia, and Other countries and regions.
About BIVI BioVie Inc.
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The Company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.